Commonwealth Scientific and Industrial Research Organisation

Other

Biotechnology Australia Pty, Ltd

Alagacone Sriskantha

Tara Sutherland

Victoria Shirley Haritos

Sarah Weisman

Gary Stewart Cobon

Keith Norman Rand

Peter Malcolm Campbell

Holly Trueman

Joanna Terry Moore

Peter Willadsen

David Harold Kemp

George Alfred Riding

Tara D Sutherland

David James Dall

Law Anthony Yorke Johnston

Jeffrey Scott Church

Law A Johnston

Michael George Huson

Carol Anne Fernon

Victoria S Haritos

Peter M Campbell

The present invention provides silk proteins, as well as nucleic acids encoding these proteins. The present invention also provides recombinant cells and/or organisms which synthesize silk proteins. Silk proteins of the invention can be used for a variety of purposes such as in the manufacture of personal care products, plastics, textiles, and biomedical products.

Silk proteins

The present invention relates to methods of producing silk dope comprising silk proteins with a coiled-coil structure such as honeybee silk proteins. The silk proteins are obtained from cells producing them, solubilizing the proteins by contacting them with a surfactant or an ionic liquid and concentrating the proteins to produce silk dope. The proteins can be used for a variety of purposes such as in the production of personal care products, plastics, textiles and biomedical products.

Processes for producing silk dope

This invention relates to an antigen isolated from the cattle tick,and to the gene coding for that antigen and to the protein product of that gene. The antigen when used in part or in entirety as an immunogen administered to cattle as a vaccine results in the production by the cattle of an immune response which is capable of damaging ticks feeding on vaccinated cattle to such an extent that the survival of such ticks is decreased and/or the reproductive capacity of the ticks is decreased to such an extent that the antigen coded for by the gene can be used as an effective vaccine against said ticks.

DNA encoding a cell membrane glycoprotein of a tick gut

Recombinant entomopoxvirus

The invention relates to antigens derived from ticks and to their purification. It also relates to genes encoding such antigens and to their cloning and expression from recombinant DNA molecules. Further, the invention describes the use of purified antigens and recombinant expression products having similar biological activity to those purified antigens to provide vaccines to protect cattle against tick infestation.

Growing community of inventors

Florey, Australia

Alagacone Sriskantha